Kemin’s Avian Influenza Summit Examines Vaccination, Biosecurity and Emerging HPAI Risks

The industry event brings attention to evolving avian-influenza challenges and the need to integrate surveillance, vaccination strategies and farm-level prevention.

15 OCTOBER 2026 — Kemin’s 2026 Avian Influenza Summit is scheduled for Today, 15th of October, bringing together industry perspectives on emerging highly pathogenic avian influenza (HPAI) risks, vaccination practices and disease-control policy. The event highlights the continuing need for coordinated prevention strategies across poultry production and veterinary health systems.

The summit is an industry knowledge-sharing event, not an announcement of a newly approved vaccine or confirmation of a new outbreak.

Why avian influenza remains a priority

Highly pathogenic avian influenza can cause severe disease and high mortality in susceptible poultry populations. Outbreaks can trigger flock losses, movement restrictions, trade disruption, surveillance costs and additional biosecurity requirements. The consequences extend beyond individual farms to hatcheries, integrators, processors and international poultry markets.

The epidemiology of avian influenza continues to evolve, making timely detection and the interpretation of surveillance data essential. Disease-control strategies need to account for circulating strains, local production systems, wild-bird interfaces and the requirements of national veterinary authorities.

Vaccination is one component of integrated control

Vaccination can be an important tool in avian-influenza prevention and control where permitted and appropriate. However, its effectiveness depends on factors such as vaccine-strain matching, administration, flock coverage, immune response and ongoing monitoring.

Vaccination should not be viewed as a replacement for biosecurity. Measures such as controlled farm access, cleaning and disinfection, safe handling of equipment, management of bird movements and rapid investigation of suspicious mortality remain essential.

Surveillance is equally important. Veterinary authorities and poultry producers need reliable information to detect infection, assess vaccine performance and identify possible viral circulation. Diagnostic testing and epidemiological investigations help distinguish between successful prevention, breakthrough infection and changes in disease patterns.

Implications for poultry integrators and suppliers

For commercial poultry companies, avian-influenza preparedness involves coordination across veterinary teams, farm managers, hatcheries, feed and water suppliers, transport operators and processing facilities.

The summit’s focus areas are relevant to several segments of the animal-health industry:

• Vaccine manufacturers: Continued emphasis on strain matching, field performance and monitoring.

• Diagnostic providers: Demand for reliable and timely testing to support surveillance and outbreak investigation.

• Biosecurity and hygiene suppliers: Farm-level prevention remains essential regardless of vaccination status.

• Poultry integrators: Preparedness planning can help reduce operational disruption and improve response coordination.

• Veterinary authorities: Surveillance, reporting and evidence-based control measures remain central to disease management.

For suppliers, increased industry attention can create opportunities for prevention products and technical services. However, an event itself does not demonstrate a change in product demand, a new approval or an improvement in disease outcomes.

Relevance for India

India’s large poultry sector makes avian-influenza preparedness an important issue for animal health, food supply and trade. Producers should follow official veterinary advisories, maintain farm biosecurity and report unusual mortality through the appropriate channels.

The summit should be viewed as a source of industry discussion rather than evidence that a new HPAI event has been confirmed in India. Local response decisions should be based on official surveillance information and veterinary guidance.

Outlook

Kemin’s Avian Influenza Summit underscores the importance of treating avian influenza as a coordinated disease-management challenge. Effective preparedness requires the integration of vaccination where appropriate, surveillance, diagnostics, biosecurity and government response.

For the animal-health industry, the key developments to monitor after the event are any formally announced product updates, validated technical findings or policy changes—not the event listing alone.